LAUSR

VJ, et al. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol 1997;28:1071–1078. 19. Nascimento ECTD, Baldi BG, Mariani AW, Annoni R, Kairalla RA, Pimenta SP, et al. Immunohistological features related to functional impairment in lymphangioleiomyomatosis. Respir Res 2018;19:83. 20. Atochina-Vasserman EN, Guo CJ, Abramova E, Golden TN, Sims M, James ML, et al. Surfactant dysfunction and lung inflammation in the female mouse model of lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 2015;53:96–104. 21. Taveira-DaSilva AM, Steagall WK, Rabel A, Hathaway O, Harari S, Cassandro R, et al. Reversible airflow obstruction in lymphangioleiomyomatosis. Chest 2009;136:1596–1603. 22. Barnes PJ. Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol 1999;104:S10–S17. 23. Soltani A, Ewe YP, Lim ZS, Sohal SS, Reid D, Weston S, et al.Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis. Eur Respir J 2012;39:1361–1367. 24. Niida Y, Stemmer-Rachamimov AO, Logrip M, Tapon D, Perez R, Kwiatkowski DJ, et al. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J HumGenet 2001; 69:493–503. 25. Niida Y, Lawrence-Smith N, Banwell A, Hammer E, Lewis J, Beauchamp RL, et al. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat 1999;14: 412–422. 26. BeauchampRL, Banwell A,McNamaraP, JacobsenM,HigginsE,Northrup H, et al.Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis. Hum Mutat 1998;12:408– 416. 27. Badri KR, Gao L, Hyjek E, Schuger N, Schuger L, Qin W, et al. Exonic mutations of TSC2/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis.AmJRespir Crit CareMed 2013; 187:663–665. 28. Johnson SR, Clelland CA, Ronan J, Tattersfield AE, Knox AJ. The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma. Histopathology 2002;40:458–463.